Table 3.
SDB-SDB Group |
P-value* | ||||
---|---|---|---|---|---|
Partner A |
Partner B |
||||
SDB Partner | Min-Max | SDB partner | Min-Max | ||
N | 22 | 22 | |||
Age (years) | 65 | 51–84 | 70 | 53–81 | 0.19 |
BMI | 33 | 22–50 | 30 | 24–53 | 0.16 |
RDI 4% | 18 | 11–75 | 23 | 11–65 | 0.43 |
Sleep onset latency | 12 | 6–80 | 14 | 6–152 | 0.92 |
Total sleep time | 385 | 221–427 | 388 | 291–427 | 0.51 |
Sleep efficiency | 81 | 63–92 | 83 | 61–94 | 0.78 |
Stage 1 % | 5 | 2–18 | 6 | 1–16 | 0.24 |
Stage 2 % | 60 | 38–80 | 64 | 35–86 | 0.80 |
Stage 3 and 4 % | 14 | 0.3–47 | 14 | 1–51 | 0.83 |
REM% | 21 | 7–35 | 22 | 11–34 | 0.94 |
Arousal index | 19 | 6–54 | 25.1 | 8–48 | 0.43 |
Habitual SOL (min) | 15 | 2–45 | 15 | 0–75 | 0.81 |
Habitual TST (min) | 480 | 300–720 | 480 | 240–600 | 0.96 |
ESS | 7 | 1–19 | 8 | 3–15 | 0.90 |
Physical functioning | 44 | 17–50 | 50 | 28–50 | 0.53 |
Bodily pain | 72 | 31–100 | 79 | 31–100 | 0.25 |
General health | 77 | 32–100 | 72 | 20–100 | 0.90 |
Vitality | 65 | 25–90 | 57.5 | 5–85 | 0.39 |
Social functioning | 100 | 50–100 | 100 | 38–100 | 0.26 |
Role-emotional | 100 | 0–100 | 100 | 0–100 | 0.52 |
Mental health | 84 | 56–96 | 88 | 44–96 | 0.85 |
P-value for Wilcoxon matched-pairs signed-ranks test. ESS (Epworth Sleepiness Scale).